PVI
BMY icon

Pura Vida Investments’s Bristol-Myers Squibb BMY Stock Holding History

Pura Vida Investments’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-200,000
Closed -$15.4M – 211
2022
Q2 		$15.4M Buy
+200,000
New +$15.2M 0.89% 30
2018
Q1 		– Sell
-50,000
Closed -$3.06M – 70
2017
Q4 		$3.06M Buy
+50,000
New +$3.13M 1.28% 34

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pura Vida Investments's BMY Position: Q4 2020 in Review

Pura Vida Investments sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 87,469 shares — an estimated $5.27M sold.

Pura Vida Investments first reported a position in BMY in Q2 2015 and held it in 6 quarters. The position peaked at $6.34M in Q2 2016. 2,360 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

  • Pura Vida Investments reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
  • Pura Vida Investments sold 87,469 Bristol-Myers Squibb shares in Q4 2020, an estimated $5.27M.
  • Pura Vida Investments first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 6 quarters.
  • Pura Vida Investments's Bristol-Myers Squibb position peaked at $6.34M in Q2 2016.
  • 2,360 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Pura Vida Investments's 13F filing for Q4 2020, filed 16 Feb 2021.